These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 11359882)
1. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. Han X; Holtzman DM; McKeel DW J Neurochem; 2001 May; 77(4):1168-80. PubMed ID: 11359882 [TBL] [Abstract][Full Text] [Related]
2. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. Han X; M Holtzman D; McKeel DW; Kelley J; Morris JC J Neurochem; 2002 Aug; 82(4):809-18. PubMed ID: 12358786 [TBL] [Abstract][Full Text] [Related]
3. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study. Cheng H; Xu J; McKeel DW; Han X Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918 [TBL] [Abstract][Full Text] [Related]
4. A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer's disease. Smith T; Knudsen KJ; Ritchie SA Brain Res; 2024 Nov; 1843():149132. PubMed ID: 39053687 [TBL] [Abstract][Full Text] [Related]
5. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease. Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572 [TBL] [Abstract][Full Text] [Related]
6. Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens. Dorninger F; Brodde A; Braverman NE; Moser AB; Just WW; Forss-Petter S; Brügger B; Berger J Biochim Biophys Acta; 2015 Feb; 1851(2):117-28. PubMed ID: 25463479 [TBL] [Abstract][Full Text] [Related]
9. Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens. Farooqui AA; Rapoport SI; Horrocks LA Neurochem Res; 1997 Apr; 22(4):523-7. PubMed ID: 9130265 [TBL] [Abstract][Full Text] [Related]
10. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects. Wood PL; Barnette BL; Kaye JA; Quinn JF; Woltjer RL Acta Neuropsychiatr; 2015 Oct; 27(5):270-8. PubMed ID: 25858158 [TBL] [Abstract][Full Text] [Related]
11. Lipidomic Analysis of Postmortem Prefrontal Cortex Phospholipids Reveals Changes in Choline Plasmalogen Containing Docosahexaenoic Acid and Stearic Acid Between Cases With and Without Alzheimer's Disease. Otoki Y; Kato S; Nakagawa K; Harvey DJ; Jin LW; Dugger BN; Taha AY Neuromolecular Med; 2021 Mar; 23(1):161-175. PubMed ID: 33475971 [TBL] [Abstract][Full Text] [Related]
12. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. Grimm MO; Grösgen S; Riemenschneider M; Tanila H; Grimm HS; Hartmann T J Chromatogr A; 2011 Oct; 1218(42):7713-22. PubMed ID: 21872257 [TBL] [Abstract][Full Text] [Related]
13. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease. Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746 [TBL] [Abstract][Full Text] [Related]
14. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. Guan Z; Wang Y; Cairns NJ; Lantos PL; Dallner G; Sindelar PJ J Neuropathol Exp Neurol; 1999 Jul; 58(7):740-7. PubMed ID: 10411344 [TBL] [Abstract][Full Text] [Related]
15. Changes in the amounts of myelin lipids and molecular species of plasmalogen PE in the brain of an autopsy case with D-bifunctional protein deficiency. Saitoh M; Yamashita S; Shimozawa N; Mizuguchi M; Iwamori M Neurosci Lett; 2008 Sep; 442(1):4-9. PubMed ID: 18611434 [TBL] [Abstract][Full Text] [Related]
16. Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. Igarashi M; Ma K; Gao F; Kim HW; Rapoport SI; Rao JS J Alzheimers Dis; 2011; 24(3):507-17. PubMed ID: 21297269 [TBL] [Abstract][Full Text] [Related]
18. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease. González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826 [TBL] [Abstract][Full Text] [Related]
19. Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis. Cheng H; Wang M; Li JL; Cairns NJ; Han X J Neurochem; 2013 Dec; 127(6):733-8. PubMed ID: 23865640 [TBL] [Abstract][Full Text] [Related]
20. Mouse brain plasmalogens are targets for hypochlorous acid-mediated modification in vitro and in vivo. Ullen A; Fauler G; Köfeler H; Waltl S; Nusshold C; Bernhart E; Reicher H; Leis HJ; Wintersperger A; Malle E; Sattler W Free Radic Biol Med; 2010 Dec; 49(11):1655-65. PubMed ID: 20807565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]